FDA Commissioner Margaret Hamburg said she will visit China next year to look into safety policies related to imported products. The agency is hiring more staff, leveraging science and working on other means to speed up drug-approval reviews, Hamburg said at the Reuters Health Summit.

Full Story:

Related Summaries